StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioAtla's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 21.1% from the year before. The highest annual figure on record is 1M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+21.1%
FY2024Dec 31, 20241M+1.7%
FY2023Dec 31, 20231M+22.7%
FY2022Dec 31, 20221M+12.6%
FY2021Dec 31, 20211M+310.1%
FY2020Dec 31, 20200M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262M+42.0%
Q1 FY2026Mar 31, 20262M+28.9%
Q4 FY2025Dec 31, 20251M+20.4%
Q3 FY2025Sep 30, 20251M+21.5%
Q2 FY2025Jun 30, 20251M+21.3%
Q1 FY2025Mar 31, 20251M+21.1%
Q4 FY2024Dec 31, 20241M+3.5%
Q3 FY2024Sep 30, 20241M+1.0%
Q2 FY2024Jun 30, 20241M+1.1%
Q1 FY2024Mar 31, 20241M+1.1%
Q4 FY2023Dec 31, 20231M+10.5%
Q3 FY2023Sep 30, 20231M+27.5%
Q2 FY2023Jun 30, 20231M+27.5%
Q1 FY2023Mar 31, 20231M+27.5%
Q4 FY2022Dec 31, 20221M+17.5%
Q3 FY2022Sep 30, 20221M+10.6%
Q2 FY2022Jun 30, 20221M+11.1%
Q1 FY2022Mar 31, 20221M+11.0%
Q4 FY2021Dec 31, 20211M-54.3%
Q3 FY2021Sep 30, 20211M–
Q2 FY2021Jun 30, 20211M–
Q1 FY2021Mar 31, 20211M–
Q3 FY2020Sep 30, 20202M–

More BioAtla figures

See a number that looks wrong?